Guangzhou LBP Medicine Science & Technology Co., Ltd.
688393
Rank in Stocks
#15748
Guangzhou LBP Medicine Science & Technology Co., Ltd. specializes in the... Guangzhou LBP Medicine Science & Technology Co., Ltd. specializes in the development and manufacture of innovative pathological diagnostic solutions for the Chinese market. Its comprehensive product portfolio includes advanced pathological diagnostic reagents and essential ancillary equipment. Among these are liquid-based cytology (LBC) offerings, encompassing both gynecological and non-gynecological series, complemented by specialized equipment. The company also provides fluorescence in situ hybridization (FISH) products, which are applied across a broad spectrum of conditions. These applications range from various cancers, including breast, bladder, lung, cervical, prostate, and thyroid, to other complex diagnoses such as neuroblastoma, soft tissue sarcoma, diverse solid tumors, prenatal screening, complications in abortion, oligodendrocytes tumors, lymphoma, multiple myeloma, and several forms of leukemia (chronic myelogenous, chronic lymphocytic, acute myeloid, and acute lymphoblastic), as well as myelodysplastic syndromes. Furthermore, GLBP offers immunohistochemistry (IHC) products, comprising a range of antibodies, advanced detection and repair systems, complementary products, and complete IHC kits. Additionally, its capabilities extend to molecular genetic diagnosis products. Established in 2005, Guangzhou LBP Medicine Science & Technology Co., Ltd. is headquartered in Guangzhou, China.
Share Price
$2.62
Last synced: 2026-11-10
Market Cap
$245.25M
Change (1 day)
0.52%
Change (1 year)
-29.51%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393)
Category
Healthcare
Operating Margin for Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393)
Operating Margin as of November 2026 TTM: -10.45%
According to Guangzhou LBP Medicine Science & Technology Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -10.45%. At the end of 2025 the company had an operating margin of -20.91%.
Operating Margin history for Guangzhou LBP Medicine Science & Technology Co., Ltd. from 2011 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -10.45% | -50.02% |
| 2025 | -20.91% | -993.59% |
| 2024 | 2.34% | -45.96% |
| 2023 | 4.33% | -23.36% |
| 2022 | 5.65% | -72.11% |
| 2021 | 20.26% | -24.09% |
| 2020 | 26.69% | 6.76% |
| 2019 | 25.00% | 2.97% |
| 2018 | 24.28% | 4.30% |
| 2017 | 23.28% | 19.51% |
| 2016 | 19.48% | -31.00% |
| 2013 | 28.23% | 4.71% |
| 2012 | 26.96% | -13.51% |
| 2011 | 31.17% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 28.37% | -102.71% |
US
|
|
| 12.36% | -101.18% |
FR
|
|
| 9.83% | -100.94% |
US
|
|
| 31.11% | -102.98% |
JP
|
|
| 9.87% | -100.94% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Guangzhou LBP Medicine Science & Technology Co., Ltd.'s operating margin
What is Guangzhou LBP Medicine Science & Technology Co., Ltd.'s operating margin?
Guangzhou LBP Medicine Science & Technology Co., Ltd.'s operating margin is -10.45%, as of Nov 2026.
What was Guangzhou LBP Medicine Science & Technology Co., Ltd.'s operating margin in 2025?
In 2025, Guangzhou LBP Medicine Science & Technology Co., Ltd.'s operating margin was -20.91%, compared with 2.34% in 2024.
How has Guangzhou LBP Medicine Science & Technology Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Guangzhou LBP Medicine Science & Technology Co., Ltd.'s operating margin was highest in 2020 (26.69%) and lowest in 2025 (-20.91%).
How does Guangzhou LBP Medicine Science & Technology Co., Ltd.'s operating margin compare with similar companies?
Guangzhou LBP Medicine Science & Technology Co., Ltd.'s operating margin (-10.45%) is lower than that of all 5 similar companies listed above. The highest among them is HOYA Corporation, with 31.11%.